NASDAQ
Avecho Biotechnology Limited (AVEFF) has a free cash flow growth of -175.63% as of Friday, May 29, 2026. This represents a 1.45% increase compared to its 12-month average of -178.21%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.